Melqart Asset Management »

Cerevel Therapeutics Hldng I shares owned by Melqart Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Melqart Asset Management from 13F filings

Historical chart of Melqart Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Melqart Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Melqart Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 286k 42.40

More positions owned by Melqart Asset Management

Pioneer Natural Resources (PXD)
stock
Exxon Mobil Corporation Put Option (XOM)
Hess (HES)
Capri Holdings SHS (CPRI)
United States Steel Corporation (X)
Amedisys (AMED)
Amazon (AMZN)
Albertsons Cos Common Stock (ACI)
NVIDIA Corporation (NVDA)
Silicon Motion Technology Sponsored Adr (SIMO)
Willscot Mobil Mini Hldng Com Cl A (WSC)
Snowflake Cl A (SNOW)
Tower Semiconductor Shs New (TSEM)
Mongodb Cl A (MDB)

View all positions for Melqart Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I